Precision BioSciences, Inc.
DTIL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $13 | $18 | $29 | $638 |
| % Growth | -27.8% | -37.9% | -95.5% | – |
| Cost of Goods Sold | $674 | $696 | $0 | $0 |
| Gross Profit | -$661 | -$678 | $29 | $638 |
| % Margin | -5,084.6% | -3,766.7% | 100% | 100% |
| R&D Expenses | $13,043 | $12,438 | $13,588 | $15,907 |
| G&A Expenses | $0 | $9,127 | $8,553 | $9,577 |
| SG&A Expenses | $6,963 | $9,127 | $8,553 | $9,577 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$366 | $0 | $0 |
| Operating Expenses | $20,006 | $21,199 | $22,141 | $25,484 |
| Operating Income | -$20,667 | -$21,877 | -$22,112 | -$24,846 |
| % Margin | -158,976.9% | -121,538.9% | -76,248.3% | -3,894.4% |
| Other Income/Exp. Net | -$1,105 | -$1,643 | $1,547 | $7,101 |
| Pre-Tax Income | -$21,772 | -$23,520 | -$20,565 | -$17,745 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$21,772 | -$23,520 | -$20,565 | -$17,745 |
| % Margin | -167,476.9% | -130,666.7% | -70,913.8% | -2,781.3% |
| EPS | -1.842 | -2.13 | -2.3 | -2.51 |
| % Growth | 13.5% | 7.4% | 8.4% | – |
| EPS Diluted | -1.842 | -2.13 | -2.29 | -2.5 |
| Weighted Avg Shares Out | 11,818 | 11,046 | 8,940 | 6,833 |
| Weighted Avg Shares Out Dil | 11,818 | 11,046 | 8,965 | 6,884 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,027 | $1,116 | $1,323 | $1,494 |
| Interest Expense | $362 | $358 | $354 | $392 |
| Depreciation & Amortization | $674 | $696 | $705 | $757 |
| EBITDA | -$20,736 | -$22,466 | -$19,506 | -$16,596 |
| % Margin | -159,507.7% | -124,811.1% | -67,262.1% | -2,601.3% |